- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2010
- Public Summary Document (PSD) November 2010 PBAC Meeting - PDF
Bevacizumab – November 2010
Bevacizumab, solution for intravenous infusion, 100 mg in 4 mL and 400 mg in 16 mL, Avastin®
Last updated
17 March 2011